[HTML][HTML] Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies
Chimeric antigen receptor (CAR)-mediated targeting of T lineage antigens for the therapy of
blood malignancies is frequently complicated by self-targeting of CAR T cells or their …
blood malignancies is frequently complicated by self-targeting of CAR T cells or their …
[HTML][HTML] Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies
N Watanabe, F Mo, R Zheng, R Ma, VC Bray… - Molecular …, 2023 - ncbi.nlm.nih.gov
Chimeric antigen receptor (CAR)-mediated targeting of T lineage antigens for the therapy of
blood malignancies is frequently complicated by self-targeting of CAR T cells or their …
blood malignancies is frequently complicated by self-targeting of CAR T cells or their …
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies
N Watanabe, F Mo, R Zheng, R Ma… - … therapy: the journal …, 2023 - pubmed.ncbi.nlm.nih.gov
Chimeric antigen receptor (CAR)-mediated targeting of T lineage antigens for the therapy of
blood malignancies is frequently complicated by self-targeting of CAR T cells or their …
blood malignancies is frequently complicated by self-targeting of CAR T cells or their …
[HTML][HTML] Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies
N Watanabe, F Mo, R Zheng, R Ma, VC Bray… - Molecular Therapy, 2023 - Elsevier
Chimeric antigen receptor (CAR)-mediated targeting of T lineage antigens for the therapy of
blood malignancies is frequently complicated by self-targeting of CAR T cells or their …
blood malignancies is frequently complicated by self-targeting of CAR T cells or their …
Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T-cells for T-cell malignancies.
N Watanabe, F Mo, R Zheng, R Ma… - … Therapy: the Journal …, 2022 - europepmc.org
CAR-mediated targeting of T-lineage antigens for the therapy of blood malignancies is
frequently complicated by self-targeting of CAR T-cells or their excessive differentiation …
frequently complicated by self-targeting of CAR T-cells or their excessive differentiation …
[引用][C] Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies
N Watanabe, F Mo, R Zheng, R Ma, VC Bray… - Molecular …, 2023 - europepmc.org
Chimeric antigen receptor (CAR)-mediated targeting of T lineage antigens for the therapy of
blood malignancies is frequently complicated by self-targeting of CAR T cells or their …
blood malignancies is frequently complicated by self-targeting of CAR T cells or their …